发明名称 |
Peptide-based immunotherapeutic agent |
摘要 |
A peptide-based immunotherapeutic agent effective for every allergy patient is provided. A reagent for typing HLA class II molecules of the patient to be used in selecting a peptide-based immunotherapeutic agent effective for every allergy patient is also provided. The peptide-based immunotherapeutic agent enables the optimal peptide-based immunotherapy for each patient, so that a marked improvement in peptide-immunotherapy can be expected. The peptide-based immunotherapeutic agent is also effective for patients who cannot be treated by peptide-based immunotherapy using major antigen peptide recognized in a particular patient population. Furthermore, the peptide-based immunotherapeutic agent enables simple and easy typing of HLA class II molecules of allergy patients.
|
申请公布号 |
US7025964(B1) |
申请公布日期 |
2006.04.11 |
申请号 |
US19990308027 |
申请日期 |
1999.08.16 |
申请人 |
MEIJI DAIRIES CORPORATION |
发明人 |
SONE TOSHIO;KUME AKINORI;DAIRIKI KAZUO;KINO KOHSUKE |
分类号 |
A61K39/35;A61K39/36;A61K38/00;A61P37/08;C07K7/00;C07K14/415;G01N33/569 |
主分类号 |
A61K39/35 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|